<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8114493</article-id>
    <article-id pub-id-type="publisher-id">3868</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-020-03868-w</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DSCMF: prediction of LncRNA-disease associations based on dual sparse collaborative matrix factorization</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Jin-Xing</given-names>
        </name>
        <address>
          <email>sdcavell@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gao</surname>
          <given-names>Ming-Ming</given-names>
        </name>
        <address>
          <email>gaommzjr@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cui</surname>
          <given-names>Zhen</given-names>
        </name>
        <address>
          <email>cuizhensdws@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Gao</surname>
          <given-names>Ying-Lian</given-names>
        </name>
        <address>
          <email>yinliangao@126.com</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Feng</given-names>
        </name>
        <address>
          <email>lifeng_10_28@163.com</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.412638.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0227 8151</institution-id><institution>School of Computer Science, </institution><institution>Qufu Normal University, </institution></institution-wrap>Rizhao, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.412638.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0227 8151</institution-id><institution>Qufu Normal University Library, </institution><institution>Qufu Normal University, </institution></institution-wrap>Rizhao, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>12</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>12</day>
      <month>5</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>22</volume>
    <issue>Suppl 3</issue>
    <issue-sponsor>Publication of this supplement has not been supported by sponsorship. Information about the source of funding for publication charges can be found in the individual articles. The articles have undergone the journal's standard peer review process for supplements. The Supplement Editors were not involved in the peer review of any article they co-authored. No other competing interests were declared.</issue-sponsor>
    <elocation-id>241</elocation-id>
    <history>
      <date date-type="received">
        <day>29</day>
        <month>10</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>9</day>
        <month>11</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">In the development of science and technology, there are increasing evidences that there are some associations between lncRNAs and human diseases. Therefore, finding these associations between them will have a huge impact on our treatment and prevention of some diseases. However, the process of finding the associations between them is very difficult and requires a lot of time and effort. Therefore, it is particularly important to find some good methods for predicting lncRNA-disease associations (LDAs).</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">In this paper, we propose a method based on dual sparse collaborative matrix factorization (DSCMF) to predict LDAs. The DSCMF method is improved on the traditional collaborative matrix factorization method. To increase the sparsity, the L<sub>2,1</sub>-norm is added in our method. At the same time, Gaussian interaction profile kernel is added to our method, which increase the network similarity between lncRNA and disease. Finally, the AUC value obtained by the experiment is used to evaluate the quality of our method, and the AUC value is obtained by the ten-fold cross-validation method.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">The AUC value obtained by the DSCMF method is 0.8523. At the end of the paper, simulation experiment is carried out, and the experimental results of prostate cancer, breast cancer, ovarian cancer and colorectal cancer are analyzed in detail. The DSCMF method is expected to bring some help to lncRNA-disease associations research. The code can access the <ext-link ext-link-type="uri" xlink:href="https://github.com/Ming-0113/DSCMF">https://github.com/Ming-0113/DSCMF</ext-link> website.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>LncRNA-disease associations</kwd>
      <kwd>Gaussian interaction profile kernel</kwd>
      <kwd>Collaborative matrix factorization</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>61872220</award-id>
        <award-id>61902216</award-id>
        <principal-award-recipient>
          <name>
            <surname>Liu</surname>
            <given-names>Jin-Xing</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Feng</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <conference xlink:href="http://ic-ic.tongji.edu.cn/2019/index.htm">
      <conf-name>Fifteenth International Conference on Intelligent Computing (ICIC 2019)</conf-name>
      <conf-loc>Nanchang, China</conf-loc>
      <conf-date>3-6 August 2019</conf-date>
    </conference>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec2">
    <title>Background</title>
    <p id="Par9">In recent years, science and technology have developed rapidly, and many experts and scholars are paying more and more attention to long non-coding RNAs (lncRNAs). The length of lncRNAs is more than 200 nucleotides, and it is not involved in encoding protein functions [<xref ref-type="bibr" rid="CR1">1</xref>]. Many experiments have demonstrated that lncRNAs play an important role in many aspects, such as epigenetic regulation, cell cycle control and cell differentiation regulation [<xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. However, the current understanding of lncRNAs is still far from enough, and many unknown areas still need us to explore them. Therefore, we still need to strengthen the research on lncRNAs, which will also contribute to the better development of human biology.</p>
    <p id="Par10">There are increasing evidences that lncRNAs are closely linked to many human diseases, such as common cardiovascular diseases [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>], diabetes [<xref ref-type="bibr" rid="CR7">7</xref>], Alzheimer's [<xref ref-type="bibr" rid="CR8">8</xref>] and some cancers. LncRNA like MALAT1 is a transcript that is overexpressed in many cancers [<xref ref-type="bibr" rid="CR9">9</xref>]. It is closely related to diseases such as lung cancer [<xref ref-type="bibr" rid="CR10">10</xref>], renal cancer [<xref ref-type="bibr" rid="CR11">11</xref>] and esophageal cancer [<xref ref-type="bibr" rid="CR12">12</xref>]. Another example is GAS5, which is related to head and neck cancer [<xref ref-type="bibr" rid="CR13">13</xref>], colon cancer [<xref ref-type="bibr" rid="CR14">14</xref>], thyroid cancer [<xref ref-type="bibr" rid="CR15">15</xref>], etc. Although some LDAs databases have been established for research by experts and scholars, the number of known LDAs in the database are far from enough, and there are many unknown associations that require people to mine them. Therefore, it is very necessary to find a method for efficient and accurate LDAs prediction.</p>
    <p id="Par11">At present, many methods have been proposed in the aspect of LDAs prediction [<xref ref-type="bibr" rid="CR16">16</xref>]. These methods have helped more or less for predictions. For example, Sun et al. proposed a new computational model that used random walk with restart methods on the lncRNA functional similarity network [<xref ref-type="bibr" rid="CR17">17</xref>]. A lncRNA-lncRNA functional similarity network was constructed, and the relationship between similar phenotypic diseases and functionally similar lncRNAs was used to predict novel associations. Finally, it was found through experiments that this method is indeed feasible. Chen et al. improved on the basis of the random walk with restart model, combining the disease semantic similarity matrix with the lncRNA expression similarity matrix, and setting the initial probability vector of the random walk with restart model [<xref ref-type="bibr" rid="CR18">18</xref>]. Therefore, this model can be applied to studies of diseases without known related lncRNAs. Chen et al. proposed a Laplacian regularized least squares method to predict novel associations based on the assumption that similar diseases may be related to functionally similar lncRNAs [<xref ref-type="bibr" rid="CR19">19</xref>]. This method was developed under the framework of semi-supervised learning and can be used to sort the candidate disease-lncRNA pairs for all diseases. Chen proposed a KATZ measurement model to predict novel LDAs by combining lncRNA expression similarity and functional similarity, as well as disease semantic similarity and GIP kernel similarity [<xref ref-type="bibr" rid="CR20">20</xref>]. This method can predict lncRNAs with no known associations for those diseases or those with no known associations for lncRNAs. Ding et al. proposed a way to combine the gene-disease association network with the lncRNA-disease association network into a lncRNA-disease-gene tripartite graph for prediction [<xref ref-type="bibr" rid="CR21">21</xref>]. The advantage of this method is that it can better describe the heterogeneity of coding-non-coding genes-disease associations than other methods. Ping et al. proposed a method of constructing a bipartite network to predict novel LDAs [<xref ref-type="bibr" rid="CR22">22</xref>]. This method is based on the known topology of the lncRNA-disease network to identify those potential LDAs. Finally, the Leave-one-out cross-validation method was used to evaluate the performance of the method. Zhao et al. proposed a method for predicting novel LDAs without relying on any known lncRNA-disease association [<xref ref-type="bibr" rid="CR23">23</xref>]. This method is based on distance correlation set that combines known lncRNA-miRNA associations and miRNA-disease associations to predict novel associations. The result proves that this method is effective and has great advantages. Ou-Yang et al. proposed a new method for predicting LDAs, called the two-side sparse self-representation method [<xref ref-type="bibr" rid="CR24">24</xref>]. The advantage of this approach is that it can adaptively learn the self-characterization of lncRNAs and the self-characterization of diseases, a process based on the known LDAs. And this method can also be supported from the internal associations between diseases and lncRNAs. Fu et al. proposed a matrix factorization model, which mainly decomposes the data matrix of heterogeneous data sources into low-rank matrix by matrix [<xref ref-type="bibr" rid="CR25">25</xref>].</p>
    <p id="Par12">In this paper, an improved matrix factorization model is proposed to predict LDAs. This method mainly uses the collaborative matrix factorization, and then joins the Gaussian interaction profile kernel. At the same time, the L<sub>2,1</sub>-norm is added to prevent over-fitting [<xref ref-type="bibr" rid="CR26">26</xref>–<xref ref-type="bibr" rid="CR28">28</xref>]. Since there may be some missing associations in the course of the experiment, the accuracy of our predictions will be reduced, so we also add the weight K nearest known neighbors (WKNKN) pre-processing process. The cross-validation method is used to obtain the AUC value of this method. At the end of the paper, the simulation experiment is carried out. The results show that our method is indeed superior to other methods. The specific improvements to our approach are as follows:<list list-type="bullet"><list-item><p id="Par13">In the DSCMF method, the L<sub>2,1</sub>-norm is introduced to sparse <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M2"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq1.gif"/></alternatives></inline-formula> and <inline-formula id="IEq2"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M4"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq2.gif"/></alternatives></inline-formula>, which reduces redundant data, improves the computational power of the model, improves the robustness of the algorithm, and reduces the influence of noise on the <inline-formula id="IEq3"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M6"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq3.gif"/></alternatives></inline-formula> and <inline-formula id="IEq4"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M8"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq4.gif"/></alternatives></inline-formula> matrices.</p></list-item><list-item><p id="Par14">Network similarity is added to the DSCMF method, and we add the lncRNA network similarity matrix and the disease network similarity matrix to our method.</p></list-item></list></p>
    <p id="Par15">In the second part of this paper, we show the experimental results of the DSCMF method. The third and fourth parts discuss and summarize the DSCMF method respectively, and put forward the next work plan. The specific algorithm and detailed formula of the DSCMF method can be seen in the fifth part of this article.</p>
  </sec>
  <sec id="Sec3">
    <title>Results</title>
    <sec id="Sec4">
      <title>Human LncRNA-disease associations</title>
      <p id="Par16">The LncRNADisease database is a common database for studying lncRNA-disease associations [<xref ref-type="bibr" rid="CR29">29</xref>]. This database contains 247 diseases, 369 lncRNAs and their associations. These associations were previously verified by 687 experiments [<xref ref-type="bibr" rid="CR21">21</xref>]. The data used in this paper are 178 diseases without disease ontology (<ext-link ext-link-type="uri" xlink:href="https://disease-ontology.org/">https://disease-ontology.org/</ext-link>) and 115 lncRNAs without expression profiles selected from ArrayExpress (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/arrayexpress/">https://www.ebi.ac.uk/arrayexpress/</ext-link>) [<xref ref-type="bibr" rid="CR30">30</xref>]. Finally, we get a dataset with 540 lncRNA-disease associations, as listed in Table <xref rid="Tab1" ref-type="table">1</xref>. <inline-formula id="IEq5"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{Y}}$$\end{document}</tex-math><mml:math id="M10"><mml:mi mathvariant="bold">Y</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq5.gif"/></alternatives></inline-formula> is an adjacency matrix. If the value of this element is 1, this lncRNA <inline-formula id="IEq6"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l\left( i \right)$$\end{document}</tex-math><mml:math id="M12"><mml:mrow><mml:mi>l</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq6.gif"/></alternatives></inline-formula> is related to the disease <inline-formula id="IEq7"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d(j)$$\end{document}</tex-math><mml:math id="M14"><mml:mrow><mml:mi>d</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>j</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq7.gif"/></alternatives></inline-formula>. Otherwise, it implies that the lncRNA has nothing to do with this disease. The ten-fold cross-validation method is applied in this paper, and the above dataset is used as the gold standard dataset for experiments to predict novel LDAs.<table-wrap id="Tab1"><label>Table 1</label><caption><p>LncRNAs, diseases, and associations in Gold Standard Dataset</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Datasets</th><th align="left">LncRNAs</th><th align="left">Diseases</th><th align="left">Associations</th></tr></thead><tbody><tr><td align="left">Gold standard dataset</td><td char="." align="char">115</td><td char="." align="char">178</td><td char="." align="char">540</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec5">
      <title>Cross validation</title>
      <p id="Par17">Cross-validation is used as an evaluation method in our experiments. And compared with the previously proposed LRLSLDA [<xref ref-type="bibr" rid="CR19">19</xref>], ncPred [<xref ref-type="bibr" rid="CR31">31</xref>], TPGLDA [<xref ref-type="bibr" rid="CR21">21</xref>] and NTSHMDA [<xref ref-type="bibr" rid="CR32">32</xref>] methods. The experiment process mainly uses the ten-fold cross-validation method. At the same time, in order to ensure the stability and reliability of our experimental results, each method is repeated 30 times. It should be noted that some unknown associations may be lost. To avoid this, the WKNKN pre-processing process is applied to our method.</p>
      <p id="Par18">At the end of the final experiment, a corresponding AUC value [<xref ref-type="bibr" rid="CR33">33</xref>] will be generated. This AUC value is an evaluation indicator used to evaluate the quality of our method. To know the AUC value, you need to know the area under the receiver operating characteristic (ROC) curve. The AUC value is equivalent to the area under the ROC curve. ROC curve is related to true positive rate (TPR) and false positive rate (FPR). The calculation formula is as follows:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TPR = \frac{TP}{{TP + FN}},$$\end{document}</tex-math><mml:math id="M16" display="block"><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$FPR = \frac{FP}{{TN + FP}},$$\end{document}</tex-math><mml:math id="M18" display="block"><mml:mrow><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mi>R</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">FP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq8"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TP$$\end{document}</tex-math><mml:math id="M20"><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq8.gif"/></alternatives></inline-formula> and <inline-formula id="IEq9"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$TN$$\end{document}</tex-math><mml:math id="M22"><mml:mrow><mml:mi mathvariant="italic">TN</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq9.gif"/></alternatives></inline-formula> represent the number of positive and negative samples that are true. <inline-formula id="IEq10"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$FP$$\end{document}</tex-math><mml:math id="M24"><mml:mrow><mml:mi mathvariant="italic">FP</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq10.gif"/></alternatives></inline-formula> and <inline-formula id="IEq11"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$FN$$\end{document}</tex-math><mml:math id="M26"><mml:mrow><mml:mi mathvariant="italic">FN</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq11.gif"/></alternatives></inline-formula> represent the number of positive and negative samples that are false.</p>
      <p id="Par19">The area under the ROC curve is a number not greater than 1, that is, the AUC value is a number between 0 and 1. Generally, according to past experience, the AUC value is a number between 0.5 and 1. If it is less than 0.5, it proves that this method is not feasible.</p>
    </sec>
    <sec id="Sec6">
      <title>Comparison with other methods</title>
      <p id="Par20">The experimental results of the LRLSLDA, ncPred, TPGLDA, NTSHMDA and DSCMF methods are listed in Table <xref rid="Tab2" ref-type="table">2</xref>. In Table <xref rid="Tab2" ref-type="table">2</xref>, we show the method with the highest AUC value and its AUC value in italics. It can be clearly seen from the experimental results that the DSCMF method has the highest AUC value, followed by the NTSHMDA method, but our method is still 5.85% higher than it. The lowest AUC value is the LRLSLDA method, which is 18.98% lower than our method. A more intuitive description of the AUC values for the various methods can be found in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>AUC results of cross validation experiments</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Methods</th><th align="left">Gold standard dataset</th></tr></thead><tbody><tr><td align="left">LRLSLDA</td><td char="(" align="char">0.6625 (0.0089)</td></tr><tr><td align="left">ncPred</td><td char="(" align="char">0.7566 (0.0218)</td></tr><tr><td align="left">TPGLDA</td><td char="(" align="char">0.7586 (0.0306)</td></tr><tr><td align="left">NTSHMDA</td><td char="(" align="char">0.7938 (0.0030)</td></tr><tr><td align="left"><italic>DSCMF</italic></td><td char="(" align="char"><italic>0.8523</italic> (<italic>0.0049</italic>)</td></tr></tbody></table></table-wrap><fig id="Fig1"><label>Fig. 1</label><caption><p>The LRLSLDA, ncPred, TPGLDA, NTSHMDA and DSCMF methods compare the performance of the AUC and ROC curves based on the ten-fold cross-validation method. It can be seen that the DSCMF method has the best performance</p></caption><graphic xlink:href="12859_2020_3868_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par21">The above results fully show that the DSCMF method is better than the previous methods, which is more conducive to the prediction of LDAs. The DSCMF method adds a GIP kernel to the original CMF method, thereby increasing the lncRNA network similarity matrix and the disease network similarity matrix in the original method. The second is to add the L<sub>2,1</sub>-norm, which increases the sparsity. Therefore, this method has great advantages over other methods.</p>
    </sec>
    <sec id="Sec7">
      <title>Sensitivity analysis from WKNKN</title>
      <p id="Par22">In the course of the experiment, some unknown associations that often have important influence on our prediction may be lost, so in order to avoid this negative impact will affect our experimental results, WKNKN pre-processing process is introduced in the DSCMF method. In this process, the setting of the parameters will also have a certain impact on the experimental results. Different parameters may cause the AUC value to change, so the choice of parameters is particularly important. It includes the choice of two parameters, one is the <inline-formula id="IEq12"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K$$\end{document}</tex-math><mml:math id="M28"><mml:mi>K</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq12.gif"/></alternatives></inline-formula> value representing the nearest known neighbor, and the other is the attenuation parameter <inline-formula id="IEq13"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P$$\end{document}</tex-math><mml:math id="M30"><mml:mi>P</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq13.gif"/></alternatives></inline-formula>. According to previous experience, when setting <inline-formula id="IEq14"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K$$\end{document}</tex-math><mml:math id="M32"><mml:mi>K</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq14.gif"/></alternatives></inline-formula> to 5 and <inline-formula id="IEq15"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P$$\end{document}</tex-math><mml:math id="M34"><mml:mi>P</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq15.gif"/></alternatives></inline-formula> to 0.7, AUC tends to be stable. When <inline-formula id="IEq16"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K$$\end{document}</tex-math><mml:math id="M36"><mml:mi>K</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq16.gif"/></alternatives></inline-formula> is set to 5 and <inline-formula id="IEq17"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P$$\end{document}</tex-math><mml:math id="M38"><mml:mi>P</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq17.gif"/></alternatives></inline-formula> is set to 0.7, the AUC value tends to be stable. Figures <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref> show the effect of the two parameters <inline-formula id="IEq18"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K$$\end{document}</tex-math><mml:math id="M40"><mml:mi>K</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq18.gif"/></alternatives></inline-formula> and <inline-formula id="IEq19"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P$$\end{document}</tex-math><mml:math id="M42"><mml:mi>P</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq19.gif"/></alternatives></inline-formula> on AUC, respectively.<fig id="Fig2"><label>Fig. 2</label><caption><p>The sensitivity analysis for <inline-formula id="IEq88"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K$$\end{document}</tex-math><mml:math id="M44"><mml:mi>K</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq88.gif"/></alternatives></inline-formula> under CV-p</p></caption><graphic xlink:href="12859_2020_3868_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>The sensitivity analysis for <inline-formula id="IEq89"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P$$\end{document}</tex-math><mml:math id="M46"><mml:mi>P</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq89.gif"/></alternatives></inline-formula> under CV-p</p></caption><graphic xlink:href="12859_2020_3868_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Robust analysis of DSCMF</title>
      <p id="Par23">In this paper, we increase the L<sub>2,1</sub>-norm, and the increase of the L<sub>2,1</sub>-norm can improve the robustness of our algorithm. In order to prove the ability of the DSCMF method to learn the subspace, that is, the anti-interference ability when restoring data is strong, the DSCMF method is applied to the synthetic dataset composed of 200 two-dimensional data points, and all the data points are distributed in a one-dimensional subspace, i.e. <inline-formula id="IEq20"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y = x$$\end{document}</tex-math><mml:math id="M48"><mml:mrow><mml:mi>y</mml:mi><mml:mo>=</mml:mo><mml:mi>x</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq20.gif"/></alternatives></inline-formula>. <inline-formula id="IEq21"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x$$\end{document}</tex-math><mml:math id="M50"><mml:mi>x</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq21.gif"/></alternatives></inline-formula> and <inline-formula id="IEq22"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y$$\end{document}</tex-math><mml:math id="M52"><mml:mi>y</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq22.gif"/></alternatives></inline-formula> refer to the position of the coordinate axis where the data point is located. In addition, we also apply the original CMF method to this synthetic dataset to compare with our method. The specific process is to add different numbers of noise points in the synthesized dataset to compare the robustness of the CMF and DSCMF methods. Figure <xref rid="Fig4" ref-type="fig">4</xref> shows the data distribution after adding one noise point. It can be seen that both CMF and DSCMF methods can be relatively stable. Figures <xref rid="Fig5" ref-type="fig">5</xref>, <xref rid="Fig6" ref-type="fig">6</xref>, and <xref rid="Fig7" ref-type="fig">7</xref> show the data distribution of 30, 60, and 90 noise points respectively. It can be clearly seen that with the increase of noise points, the DSCMF method can basically maintain a stable state, basically unaffected by noise points. However, the CMF method is more affected by noise points. It is therefore proved that the DSCMF method increases the robustness.<fig id="Fig4"><label>Fig. 4</label><caption><p>The comparison of the robustness of the CMF and DSCMF methods when the noise point is 1</p></caption><graphic xlink:href="12859_2020_3868_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>The comparison of the robustness of the CMF and DSCMF methods when the noise point is 30</p></caption><graphic xlink:href="12859_2020_3868_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>The comparison of the robustness of the CMF and DSCMF methods when the noise point is 60</p></caption><graphic xlink:href="12859_2020_3868_Fig6_HTML" id="MO6"/></fig><fig id="Fig7"><label>Fig. 7</label><caption><p>The comparison of the robustness of the CMF and DSCMF methods when the noise point is 90</p></caption><graphic xlink:href="12859_2020_3868_Fig7_HTML" id="MO7"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Case study</title>
      <p id="Par24">In this section, simulation experiment is performed to predict some novel LDAs. For the predicted results, four common diseases are selected for research: prostate cancer, breast cancer, ovarian cancer, and colorectal cancer. The experimental procedure is as follows: For one of the diseases, the predicted score matrix obtained is sorted from high to low. Then several lncRNAs with the highest scores are selected for analysis and verified by the databases LncRNADisease and Lnc2cancer.</p>
      <p id="Par25">The first study is prostate cancer. Prostate cancer is an epithelial malignancy that is closely related to genetic factors and is present in the prostate. For more detailed information on prostate cancer, please visit the <ext-link ext-link-type="uri" xlink:href="https://www.omim.org/entry/176807">https://www.omim.org/entry/176807</ext-link> website. In the original gold standard dataset, 13 lncRNAs have been shown to be associated with prostate cancer. The top 20 lncRNAs in the prediction matrix are extracted and analyzed. It is found that 12 of the original 13 lncRNAs that have been shown to be associated with prostate cancer are predicted. And in Table <xref rid="Tab3" ref-type="table">3</xref>, we have indicated these 12 lncRNAs in italics. Among the remaining 8 lncRNAs, three lncRNAs, TUG1, IGF2-AS and CDKN2B-AS1, are found in the database LncRNADisease, and they are all associated with prostate cancer. Their PMIDs are 26975529 [<xref ref-type="bibr" rid="CR34">34</xref>], 19767753 [<xref ref-type="bibr" rid="CR35">35</xref>] and 23660942 [<xref ref-type="bibr" rid="CR36">36</xref>], respectively. The XIST in the table is confirmed to be associated with prostate cancer in the database Lnc2cancer, and its PMID is 29212233 [<xref ref-type="bibr" rid="CR37">37</xref>]. PTENP1, a lncRNA, is found to be associated with prostate cancer in both database LncRNADisease and Lnc2cancer. Their PMIDs are 24373479 [<xref ref-type="bibr" rid="CR38">38</xref>] and 20577206 [<xref ref-type="bibr" rid="CR39">39</xref>] respectively. The specific information is shown in Table <xref rid="Tab3" ref-type="table">3</xref>.
<table-wrap id="Tab3"><label>Table 3</label><caption><p>Predicted LncRNAs for prostate cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left"><italic>1</italic></td><td align="left"><italic>MALAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>11</italic></td><td align="left"><italic>HOTTIP</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>2</italic></td><td align="left"><italic>MEG3</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>12</italic></td><td align="left"><italic>DANCR</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>3</italic></td><td align="left"><italic>H19</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">13</td><td align="left">XIST</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>4</italic></td><td align="left"><italic>HOTAIR</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">14</td><td align="left">PTENP1</td><td align="left">LncRNADisease; Lnc2cancer</td></tr><tr><td align="left"><italic>5</italic></td><td align="left"><italic>GAS5</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">15</td><td align="left">TUG1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>6</italic></td><td align="left"><italic>PVT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">16</td><td align="left">IGF2-AS</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>7</italic></td><td align="left"><italic>UCA1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">17</td><td align="left">ZFAS1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>8</italic></td><td align="left"><italic>HULC</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">18</td><td align="left">CDKN2B-AS1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>9</italic></td><td align="left"><italic>KCNQ1OT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">19</td><td align="left">CCAT1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>10</italic></td><td align="left"><italic>NEAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">20</td><td align="left">SNHG16</td><td align="left">Unconfirmed</td></tr></tbody></table></table-wrap></p>
      <p id="Par26">The second disease is breast cancer. Breast cancer has become a common disease that threatens women's physical and mental health. For more detailed information about breast cancer, please visit: <ext-link ext-link-type="uri" xlink:href="https://www.omim.org/entry/114480">https://www.omim.org/entry/114480</ext-link>. In the gold standard dataset of the experiment, there are 20 kinds of lncRNA related to breast cancer. Comparing the predictions of the first 30 lncRNAs predicted in the simulation experiment, we find that the 17 lncRNAs in our experiment are confirmed in the gold standard dataset. These 17 lncRNAs are specifically indicated in italics in Table <xref rid="Tab4" ref-type="table">4</xref>. And 2 of the remaining 13 are confirmed in the LncRNADisease database. The two lncRNAs are CCAT1 and TUG1. Their PMIDs are 26464701 [<xref ref-type="bibr" rid="CR40">40</xref>] and 27791993 [<xref ref-type="bibr" rid="CR41">41</xref>]. There are three lncRNAs are confirmed to be associated with breast cancer in the Lnc2cancer database, which are PTENP1, SNHG16 and TUSC7, respectively. The PMIDs of these three lncRNAs are 29085464 [<xref ref-type="bibr" rid="CR42">42</xref>], 28232182 [<xref ref-type="bibr" rid="CR43">43</xref>], and 23558749 [<xref ref-type="bibr" rid="CR44">44</xref>], respectively. And KCNQ1OT1, a lncRNA, is confirmed to be associated with breast cancer in both LncRNADisease and Lnc2cancer databases. The remaining seven lncRNAs are not confirmed by the databases to be associated with breast cancer. The specific experimental results are listed in Table <xref rid="Tab4" ref-type="table">4</xref>. For example, in the case of lncRNA CCAT1, previous studies have demonstrated that CCAT1 is overexpressed than normal tissue.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Predicted LncRNAs for breast cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left"><italic>1</italic></td><td align="left"><italic>HOTAIR</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>16</italic></td><td align="left"><italic>ZFAS1</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>2</italic></td><td align="left"><italic>MALAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>17</italic></td><td align="left"><italic>CDKN2B-AS1</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>3</italic></td><td align="left"><italic>H19</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">18</td><td align="left">CCAT1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>4</italic></td><td align="left"><italic>GAS5</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">19</td><td align="left">PTENP1</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>5</italic></td><td align="left"><italic>UCA1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">20</td><td align="left">HULC</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>6</italic></td><td align="left"><italic>PVT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">21</td><td align="left">BANCR</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>7</italic></td><td align="left"><italic>BC040587</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">22</td><td align="left">SNHG16</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>8</italic></td><td align="left"><italic>XIST</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">23</td><td align="left">TUG1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>9</italic></td><td align="left"><italic>MEG3</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">24</td><td align="left">MINA</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>10</italic></td><td align="left"><italic>SPRY4-IT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">25</td><td align="left">TUSC7</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>11</italic></td><td align="left"><italic>CCAT2</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">26</td><td align="left">EPB41L4A-AS1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>12</italic></td><td align="left"><italic>BCYRN1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">27</td><td align="left">7SK</td><td align="left">Unconfirmed</td></tr></tbody></table></table-wrap></p>
      <p id="Par27">The third disease is ovarian cancer. Ovarian cancer is a common disease in female genital organs. Its incidence is second only to cervical cancer and endometrial cancer, posing a serious threat to women's health. For more detailed information on ovarian cancer please visit <ext-link ext-link-type="uri" xlink:href="https://www.omim.org/entry/167000">https://www.omim.org/entry/167000</ext-link>. In the gold standard dataset, it is known that 12 lncRNAs are associated with ovarian cancer, so the top 22 lncRNAs in the prediction matrix are selected for analysis and the results are listed in Table <xref rid="Tab5" ref-type="table">5</xref>. We successfully predict 11 lncRNAs, which have been confirmed in the gold standard dataset. At the same time, these 11 lncRNAs are shown in italics in Table <xref rid="Tab5" ref-type="table">5</xref>. Three lncRNAs are confirmed in the LncRNADisease database, which are GAS5, NEAT1, and CCAT2, and their PMID numbers are 27779700 [<xref ref-type="bibr" rid="CR45">45</xref>], 27608895 [<xref ref-type="bibr" rid="CR46">46</xref>], 27558961 [<xref ref-type="bibr" rid="CR47">47</xref>]. MEG3, SNHG16, MNX1-AS1, and ZFAS1 are confirmed to be associated with ovarian cancer in the Lnc2cancer database, and their PMIDs are 28175963 [<xref ref-type="bibr" rid="CR48">48</xref>], 29461589 [<xref ref-type="bibr" rid="CR49">49</xref>], 29271994 [<xref ref-type="bibr" rid="CR50">50</xref>], and 28154416 [<xref ref-type="bibr" rid="CR51">51</xref>], respectively. The remaining four lncRNAs are not confirmed have any association with ovarian cancer in both databases LncRNADisease and Lnc2cancer.<table-wrap id="Tab5"><label>Table 5</label><caption><p>Predicted LncRNAs for ovarian cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left"><italic>1</italic></td><td align="left"><italic>HOTAIR</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">12</td><td align="left">GAS5</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>2</italic></td><td align="left"><italic>H19</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">13</td><td align="left">MEG3</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>3</italic></td><td align="left"><italic>UCA1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">14</td><td align="left">NEAT1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>4</italic></td><td align="left"><italic>PVT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">15</td><td align="left">SPRY4-IT1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>5</italic></td><td align="left"><italic>MALAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">16</td><td align="left">CCAT2</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>6</italic></td><td align="left"><italic>XIST</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">17</td><td align="left">HULC</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>7</italic></td><td align="left"><italic>BCYRN1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">18</td><td align="left">SNHG16</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>8</italic></td><td align="left"><italic>CCAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">19</td><td align="left">BANCR</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>9</italic></td><td align="left"><italic>SRA1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">20</td><td align="left">ZFAS1</td><td align="left">Lnc2cancer</td></tr><tr><td align="left"><italic>10</italic></td><td align="left"><italic>LSINCT5</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">21</td><td align="left">PTENP1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>11</italic></td><td align="left"><italic>MNX1-AS1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">22</td><td align="left">TUSC7</td><td align="left">Unconfirmed</td></tr></tbody></table></table-wrap></p>
      <p id="Par28">The last disease listed is colorectal cancer. Colorectal cancer is a common malignant tumor in humans. China is a low-incidence area for colorectal cancer, but in recent years, the incidence of colorectal cancer has increased in different regions. As can be seen from the original gold standard dataset, the dataset contains 21 lncRNAs that are associated with colorectal cancer. 20 association pairs are successfully predicted by the DSCMF algorithm, they are shown in italics in Table <xref rid="Tab6" ref-type="table">6</xref>. And the remaining 10 lncRNAs are verified in the two databases LncRNADisease and Lnc2cancer whether they are associated with colorectal cancer. Among them, 4 lncRNAs are confirmed to be associated with colorectal cancer in the LncRNADisease database. These 4 lncRNAs are SPRY4-IT1, CDKN2B-AS1, TUG1 and ZFAS1, respectively. Their PMIDs are 27621655 [<xref ref-type="bibr" rid="CR52">52</xref>], 27286457 [<xref ref-type="bibr" rid="CR53">53</xref>], 27421138 [<xref ref-type="bibr" rid="CR54">54</xref>] and 27461828 [<xref ref-type="bibr" rid="CR55">55</xref>] respectively. There are also six lncRNAs that are not confirmed to be associated with colorectal cancer and further research is needed. Specific information on lncRNA and colorectal cancer is shown in Table <xref rid="Tab6" ref-type="table">6</xref>:<table-wrap id="Tab6"><label>Table 6</label><caption><p>Predicted LncRNAs for colorectal cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left"><italic>1</italic></td><td align="left"><italic>MALAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>16</italic></td><td align="left"><italic>TUSC7</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>2</italic></td><td align="left"><italic>HOTAIR</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>17</italic></td><td align="left"><italic>RPL34-AS1</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>3</italic></td><td align="left"><italic>MEG3</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>18</italic></td><td align="left"><italic>SNHG16</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>4</italic></td><td align="left"><italic>GAS5</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>19</italic></td><td align="left"><italic>MNX1-AS1</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>5</italic></td><td align="left"><italic>PVT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char"><italic>20</italic></td><td align="left"><italic>NPTN-IT1</italic></td><td align="left"><italic>Known</italic></td></tr><tr><td align="left"><italic>6</italic></td><td align="left"><italic>UCA1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">21</td><td align="left">SPRY4-IT1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>7</italic></td><td align="left"><italic>H19</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">22</td><td align="left">PTENP1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>8</italic></td><td align="left"><italic>XIST</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">23</td><td align="left">CDKN2B-AS1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>9</italic></td><td align="left"><italic>CCAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">24</td><td align="left">LINC00261</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>10</italic></td><td align="left"><italic>NEAT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">25</td><td align="left">BCYRN1</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>11</italic></td><td align="left"><italic>HULC</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">26</td><td align="left">TUG1</td><td align="left">LncRNADisease</td></tr><tr><td align="left"><italic>12</italic></td><td align="left"><italic>CCAT2</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">27</td><td align="left">MINA</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>13</italic></td><td align="left"><italic>BANCR</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">28</td><td align="left">7SK</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>14</italic></td><td align="left"><italic>LSINCT5</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">29</td><td align="left">BC040587</td><td align="left">Unconfirmed</td></tr><tr><td align="left"><italic>15</italic></td><td align="left"><italic>KCNQ1OT1</italic></td><td align="left"><italic>Known</italic></td><td char="." align="char">30</td><td align="left">ZFAS1</td><td align="left">LncRNADisease</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Discussion</title>
    <p id="Par29">Numerous studies have shown that lncRNA is indeed associated with certain diseases in humans, so it is a very important contribution to find some effective methods to predict these associations. However, the process of finding LDAs takes a long time and consumes a lot of energy. So, if you find some new ways to predict LDAs, this will be of great help to our research. The DSCMF method introduced in this paper mainly adds the L<sub>2,1</sub>-norm to the traditional collaborative matrix factorization method to increase the sparsity, and at the same time, the GIP kernel is used to increase the network similarity. The final cross-validation method also proves that our method is suitable for LDAs prediction. Of course, our method is not completely without disadvantages. The DSCMF method requires a long running time. Therefore, shortening the running time of our method is an important problem that we still need to solve.</p>
  </sec>
  <sec id="Sec11">
    <title>Conclusion</title>
    <p id="Par30">A ten-fold cross-validation method is used in the experimental part of this paper. And WKNKN pre-processing method is also used in the paper to solve those unknown interactions, so the accuracy of prediction is improved to the greatest extent.</p>
    <p id="Par31">In the next work, we will continue to work on this aspect of research. And, try to make up for the shortcomings in the previous research process and find some new prediction methods. At the same time, we will try to apply our method to more datasets such as miRNA-disease associations datasets, so as to more fully prove the performance of our method. At the end of the paper, I hope that the DSCMF method can be helpful for predicting lncRNA-disease associations, and we will be more committed to this research and contribute to human society.</p>
  </sec>
  <sec id="Sec12">
    <title>Methods</title>
    <sec id="Sec13">
      <title>LncRNA expression similarity</title>
      <p id="Par32">ArrayExpress contains more than 60,000 expression profiles of 16 human tissues, and these expression profiles are generated by RNA-Seq technology. The lncRNA expression profile used in this paper is obtained from ArrayExpress. The correlation between each pair of lncRNA expression profiles can be expressed using the Spearman correlation coefficient, which is also the similarity of lncRNA expression. The matrix <inline-formula id="IEq23"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}^{l}$$\end{document}</tex-math><mml:math id="M54"><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq23.gif"/></alternatives></inline-formula> can be used to represent the lncRNA expression similarity matrix, and the expression similarity between lncRNA <inline-formula id="IEq24"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l_{i}$$\end{document}</tex-math><mml:math id="M56"><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq24.gif"/></alternatives></inline-formula> and lncRNA <inline-formula id="IEq25"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l_{j}$$\end{document}</tex-math><mml:math id="M58"><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq25.gif"/></alternatives></inline-formula> can be shown in the form of <inline-formula id="IEq26"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}^{l} \left( {l_{i} ,l_{j} } \right)$$\end{document}</tex-math><mml:math id="M60"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq26.gif"/></alternatives></inline-formula>.</p>
    </sec>
    <sec id="Sec14">
      <title>Disease semantic similarity</title>
      <p id="Par33">The semantic similarity of the disease was first used in the ncRNA-disease association, and the results proved its correctness [<xref ref-type="bibr" rid="CR56">56</xref>]. In this paper, a directed acyclic graph (DAG) is used to describe the relationship between disease semantics. For disease <inline-formula id="IEq27"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D^{d}$$\end{document}</tex-math><mml:math id="M62"><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq27.gif"/></alternatives></inline-formula>, its directed acyclic graph can be expressed as <inline-formula id="IEq28"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$DAG\left( {D^{d} } \right) = \left( {D^{d} ,T\left( {D^{d} } \right),E\left( {D^{d} } \right)} \right)$$\end{document}</tex-math><mml:math id="M64"><mml:mrow><mml:mi>D</mml:mi><mml:mi>A</mml:mi><mml:mi>G</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mfenced><mml:mo>,</mml:mo><mml:mi>E</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq28.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq29"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$T\left( {D^{d} } \right)$$\end{document}</tex-math><mml:math id="M66"><mml:mrow><mml:mi>T</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq29.gif"/></alternatives></inline-formula> is represented as the set of nodes and <inline-formula id="IEq30"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$E\left( {D^{d} } \right)$$\end{document}</tex-math><mml:math id="M68"><mml:mrow><mml:mi>E</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq30.gif"/></alternatives></inline-formula> is represented as a set of edges between nodes. The specific formula is as follows:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$DV(D^{d} ) = \sum\limits_{{d \in T(D^{d} )}}^{{}} {D_{{D^{d} }}^{{}} (d)} ,$$\end{document}</tex-math><mml:math id="M70" display="block"><mml:mrow><mml:mi>D</mml:mi><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mo>∈</mml:mo><mml:mi>T</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow/></mml:munderover><mml:mrow><mml:msubsup><mml:mi>D</mml:mi><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:mrow><mml:mrow/></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>d</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$D_{{D^{d} }} (d) = \left\{ {\begin{array}{*{20}c} 1 &amp; {if\,d = D^{d} ,} \\ {\max \left\{ {\Delta * D_{{D^{d} }} \left( {d^{^{\prime}} } \right)\left| d \right.^{^{\prime}} \in children\,of\,{\text{d}}} \right\}} &amp; {if\,{\text{d}} \ne {\text{D}}^{d} ,} \\ \end{array} } \right.$$\end{document}</tex-math><mml:math id="M72" display="block"><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>d</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mn>1</mml:mn></mml:mtd><mml:mtd><mml:mrow><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.166667em"/><mml:mi>d</mml:mi><mml:mo>=</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mo movablelimits="true">max</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:mi mathvariant="normal">Δ</mml:mi><mml:mrow/><mml:mo>∗</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:msup><mml:mi>D</mml:mi><mml:mi>d</mml:mi></mml:msup></mml:msub><mml:mfenced close=")" open="("><mml:msup><mml:mi>d</mml:mi><mml:msup><mml:mrow/><mml:mo>′</mml:mo></mml:msup></mml:msup></mml:mfenced><mml:msup><mml:mfenced open="|"><mml:mi>d</mml:mi></mml:mfenced><mml:msup><mml:mrow/><mml:mo>′</mml:mo></mml:msup></mml:msup><mml:mo>∈</mml:mo><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>i</mml:mi><mml:mi>l</mml:mi><mml:mi>d</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mspace width="0.166667em"/><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.166667em"/><mml:mtext>d</mml:mtext></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="0.166667em"/><mml:mtext>d</mml:mtext><mml:mo>≠</mml:mo><mml:msup><mml:mrow><mml:mtext>D</mml:mtext></mml:mrow><mml:mi>d</mml:mi></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq31"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\Delta$$\end{document}</tex-math><mml:math id="M74"><mml:mi mathvariant="normal">Δ</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq31.gif"/></alternatives></inline-formula> represents a semantic contribution factor. Given a disease semantic similarity matrix <inline-formula id="IEq32"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}^{d}$$\end{document}</tex-math><mml:math id="M76"><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>d</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq32.gif"/></alternatives></inline-formula>. To determine the semantic similarity between the two diseases <inline-formula id="IEq33"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{i}$$\end{document}</tex-math><mml:math id="M78"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq33.gif"/></alternatives></inline-formula> and <inline-formula id="IEq34"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{j}$$\end{document}</tex-math><mml:math id="M80"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq34.gif"/></alternatives></inline-formula>, it is necessary to look at their common DAG parts. Therefore, as long as their DAG common parts are larger, their semantic similarities are greater. The specific calculation formula is as follows:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}^{d} (d_{i} ,d_{j} ) = \frac{{\sum\nolimits_{{t \in T(d_{i} ) \cap T(d_{j} )}} {(D_{{d_{i} }} (t) + D_{{d_{j} }} (t))} }}{{DV(d_{i} ) + DV(d_{j} )}}.$$\end{document}</tex-math><mml:math id="M82" display="block"><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>d</mml:mi></mml:msup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mrow><mml:mi>t</mml:mi><mml:mo>∈</mml:mo><mml:mi>T</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>∩</mml:mo><mml:mi>T</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>t</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mi>D</mml:mi><mml:mi>V</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec15">
      <title>Weight K nearest known neighbors</title>
      <p id="Par34">In order to prevent the loss of some unknown correlations and make our predictions more accurate, the WKNKN preprocessing process is added to the DSCMF method. In the lncRNA-disease association matrix <inline-formula id="IEq35"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{Y}}$$\end{document}</tex-math><mml:math id="M84"><mml:mi mathvariant="bold">Y</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq35.gif"/></alternatives></inline-formula>, if lncRNA is associated with disease, the value in the matrix is 1, otherwise it is 0. The role of pre-processing is to change these 0 or 1 to values between 0 and 1, forming a new matrix to increase the accuracy of the prediction.</p>
    </sec>
    <sec id="Sec16">
      <title>Gaussian interaction profile kernel similarity</title>
      <p id="Par35">Regardless of whether the disease is associated with the lncRNA in the lncRNA-disease network, it is likely to have a similar association with the new disease. The Gaussian interaction profile kernel similarity used in this method is based on this assumption [<xref ref-type="bibr" rid="CR57">57</xref>]. The GIP kernel similarity can be used in this method to represent the network topological structure of LDAs. The topological structure of lncRNA <inline-formula id="IEq36"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l_{i}$$\end{document}</tex-math><mml:math id="M86"><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq36.gif"/></alternatives></inline-formula>, <inline-formula id="IEq37"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l_{j}$$\end{document}</tex-math><mml:math id="M88"><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq37.gif"/></alternatives></inline-formula> and disease <inline-formula id="IEq38"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{i}$$\end{document}</tex-math><mml:math id="M90"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq38.gif"/></alternatives></inline-formula>, <inline-formula id="IEq39"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{j}$$\end{document}</tex-math><mml:math id="M92"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq39.gif"/></alternatives></inline-formula> are represented by the following formula:<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$GIP_{lncRNA} (l_{i,} l_{j} ) = \exp ( - \gamma \left\| {{\mathbf{Y}}(l_{i} ) - {\mathbf{Y}}(l_{j} )} \right\|^{2} ),$$\end{document}</tex-math><mml:math id="M94" display="block"><mml:mrow><mml:mi>G</mml:mi><mml:mi>I</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="italic">lncRNA</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>exp</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:msup><mml:mfenced close="∥" open="∥"><mml:mrow><mml:mi mathvariant="bold">Y</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant="bold">Y</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$GIP_{disease} (d_{i,} d_{j} ) = \exp ( - \gamma \left\| {{\mathbf{Y}}(d_{i} ) - {\mathbf{Y}}(d_{j} )} \right\|^{2} ).$$\end{document}</tex-math><mml:math id="M96" display="block"><mml:mrow><mml:mi>G</mml:mi><mml:mi>I</mml:mi><mml:msub><mml:mi>P</mml:mi><mml:mrow><mml:mi mathvariant="italic">disease</mml:mi></mml:mrow></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:msub><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mo>exp</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:msup><mml:mfenced close="∥" open="∥"><mml:mrow><mml:mi mathvariant="bold">Y</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi mathvariant="bold">Y</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par36">The parameters of the adjustment kernel bandwidth represented by <inline-formula id="IEq40"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\gamma$$\end{document}</tex-math><mml:math id="M98"><mml:mi>γ</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq40.gif"/></alternatives></inline-formula> in the above two formulas. <inline-formula id="IEq41"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{Y}}(l_{i} )$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mi mathvariant="bold">Y</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq41.gif"/></alternatives></inline-formula> stands for a binary vector, the <inline-formula id="IEq42"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i$$\end{document}</tex-math><mml:math id="M102"><mml:mi>i</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq42.gif"/></alternatives></inline-formula>-th row of <inline-formula id="IEq43"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{Y}}$$\end{document}</tex-math><mml:math id="M104"><mml:mi mathvariant="bold">Y</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq43.gif"/></alternatives></inline-formula>, which represents the interaction profiles of the association between <inline-formula id="IEq44"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l_{i}$$\end{document}</tex-math><mml:math id="M106"><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq44.gif"/></alternatives></inline-formula> and each disease. Next, the lncRNA expression similarity matrix and the network similarity matrix are combined by using formula (<xref rid="Equ8" ref-type="">8</xref>). Similarly, the disease semantic similarity matrix and the network similarity matrix are combined by using formula (<xref rid="Equ9" ref-type="">9</xref>).<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{K}}_{l} {\mathbf{ = }}\alpha {\mathbf{S}}^{l} + (1 - \alpha ){\mathbf{GIP}}_{l} ,$$\end{document}</tex-math><mml:math id="M108" display="block"><mml:mrow><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="bold">GIP</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{K}}_{d} {\mathbf{ = }}\alpha {\mathbf{S}}^{d} + (1 - \alpha ){\mathbf{GIP}}_{d} .$$\end{document}</tex-math><mml:math id="M110" display="block"><mml:mrow><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>α</mml:mi><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>d</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mi>α</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="bold">GIP</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par37">In the above two formulas, <inline-formula id="IEq45"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha \in \left[ {0,1} \right]$$\end{document}</tex-math><mml:math id="M112"><mml:mrow><mml:mi>α</mml:mi><mml:mo>∈</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq45.gif"/></alternatives></inline-formula>, and it is a parameter that can be adjusted. Where <inline-formula id="IEq46"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{K}}_{l}$$\end{document}</tex-math><mml:math id="M114"><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq46.gif"/></alternatives></inline-formula> is the final matrix combining lncRNA expression similarity and network similarity, and <inline-formula id="IEq47"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{K}}_{d}$$\end{document}</tex-math><mml:math id="M116"><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>d</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq47.gif"/></alternatives></inline-formula> is the final matrix that combines the semantic similarity of disease with network similarity.</p>
    </sec>
    <sec id="Sec17">
      <title>DSCMF</title>
      <p id="Par38">Collaborative filtering is introduced in the traditional CMF method [<xref ref-type="bibr" rid="CR58">58</xref>], which can accurately predict some novel LDAs. The objective function of the traditional CMF is as follows:<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} &amp; \min\nolimits_{{{\mathbf{A}},{\mathbf{B}}}} = ||{\mathbf{Y}} - {\mathbf{AB}}^{T} ||_{F}^{2} + \lambda_{h} (||{\mathbf{A}}||_{F}^{2} + ||{\mathbf{B}}||_{F}^{2} ) \\ &amp; \quad + \lambda_{l} ||{\mathbf{S}}^{l} - {\mathbf{AA}}^{\text{T}} ||_{F}^{2} + \lambda_{d} ||{\mathbf{S}}^{d} - {\mathbf{BB}}^{T} ||_{F}^{2} , \\ \end{aligned}$$\end{document}</tex-math><mml:math id="M118" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mo movablelimits="true">min</mml:mo><mml:mrow><mml:mi mathvariant="bold">A</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">Y</mml:mi></mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">AB</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mspace width="1em"/><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">AA</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>d</mml:mi></mml:msup><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">BB</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq48"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left\| \cdot \right\|_{F}$$\end{document}</tex-math><mml:math id="M120"><mml:msub><mml:mfenced close="∥" open="∥"><mml:mo>·</mml:mo></mml:mfenced><mml:mi>F</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq48.gif"/></alternatives></inline-formula> is Frobenius norm. <inline-formula id="IEq49"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{h}$$\end{document}</tex-math><mml:math id="M122"><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq49.gif"/></alternatives></inline-formula>, <inline-formula id="IEq50"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{l}$$\end{document}</tex-math><mml:math id="M124"><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq50.gif"/></alternatives></inline-formula> and <inline-formula id="IEq51"><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{d}$$\end{document}</tex-math><mml:math id="M126"><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq51.gif"/></alternatives></inline-formula> are positive parameters.</p>
      <p id="Par39">Then, the <inline-formula id="IEq52"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}^{l}$$\end{document}</tex-math><mml:math id="M128"><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq52.gif"/></alternatives></inline-formula> in the traditional collaborative matrix factorization method is replaced by <inline-formula id="IEq53"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{K}}_{l}$$\end{document}</tex-math><mml:math id="M130"><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq53.gif"/></alternatives></inline-formula>. Similarly, <inline-formula id="IEq54"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}^{d}$$\end{document}</tex-math><mml:math id="M132"><mml:msup><mml:mrow><mml:mi mathvariant="bold">S</mml:mi></mml:mrow><mml:mi>d</mml:mi></mml:msup></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq54.gif"/></alternatives></inline-formula> is replaced by <inline-formula id="IEq55"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{K}}_{d}$$\end{document}</tex-math><mml:math id="M134"><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>d</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq55.gif"/></alternatives></inline-formula>, thereby increasing the network similarity between lncRNA and disease. The improved formula is as follows:<disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} &amp; \min\nolimits_{{{\mathbf{A}},{\mathbf{B}}}} = ||{\mathbf{Y}} - {\mathbf{AB}}^{T} ||_{F}^{2} + \lambda_{h} (||{\mathbf{A}}||_{F}^{2} + ||{\mathbf{B}}||_{F}^{2} ) \\ &amp; \quad + \lambda_{l} ||{\mathbf{K}}_{l} - {\mathbf{AA}}^{\text{T}} ||_{F}^{2} + \lambda_{d} ||{\mathbf{K}}_{d} - {\mathbf{BB}}^{T} ||_{F}^{2} . \\ \end{aligned}$$\end{document}</tex-math><mml:math id="M136" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mo movablelimits="true">min</mml:mo><mml:mrow><mml:mi mathvariant="bold">A</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">Y</mml:mi></mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">AB</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mspace width="1em"/><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">AA</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">BB</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par40">At the same time, to increase the sparsity, the method in this paper adds L<sub>2,1</sub>-norm to matrix <inline-formula id="IEq56"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M138"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq56.gif"/></alternatives></inline-formula> and <inline-formula id="IEq57"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M140"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq57.gif"/></alternatives></inline-formula> respectively. The final objective function can be written as:<disp-formula id="Equ12"><label>12</label><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\begin{aligned} &amp; \min\nolimits_{{{\mathbf{A}},{\mathbf{B}}}} = ||{\mathbf{Y}} - {\mathbf{AB}}^{\text{T}} ||_{F}^{2} + \lambda_{h} (||{\mathbf{A}}||_{F}^{2} + ||{\mathbf{B}}||_{F}^{2} ) + \lambda_{h} ||{\mathbf{A}}||_{2,1} \\ &amp; \quad + \lambda_{h} ||{\mathbf{B}}||_{2,1} + \lambda_{l} ||{\mathbf{K}}_{l} - {\mathbf{AA}}^{\text{T}} ||_{F}^{2} + \lambda_{d} ||{\mathbf{K}}_{d} - {\mathbf{BB}}^{\text{T}} ||_{F}^{2} . \\ \end{aligned}$$\end{document}</tex-math><mml:math id="M142" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:msub><mml:mo movablelimits="true">min</mml:mo><mml:mrow><mml:mi mathvariant="bold">A</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">Y</mml:mi></mml:mrow><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">AB</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mrow><mml:mo stretchy="false">)</mml:mo><mml:mo>+</mml:mo></mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mspace width="1em"/><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">AA</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="bold">BB</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:msubsup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ12.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par41">The matrices <inline-formula id="IEq58"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M144"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq58.gif"/></alternatives></inline-formula> and <inline-formula id="IEq59"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M146"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq59.gif"/></alternatives></inline-formula> of this formula are two latent feature matrices produced by the decomposition of the matrix <inline-formula id="IEq60"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{Y}}$$\end{document}</tex-math><mml:math id="M148"><mml:mi mathvariant="bold">Y</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq60.gif"/></alternatives></inline-formula>. Where <inline-formula id="IEq61"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left\| {\mathbf{A}} \right\|_{F}^{2} = Tr\left( {{\mathbf{A}}^{T} {\mathbf{A}}} \right) = Tr\left( {{\mathbf{AA}}^{T} } \right)$$\end{document}</tex-math><mml:math id="M150"><mml:mrow><mml:msubsup><mml:mfenced close="∥" open="∥"><mml:mi mathvariant="bold">A</mml:mi></mml:mfenced><mml:mrow><mml:mi>F</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">A</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:mi mathvariant="bold">A</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mrow><mml:mi mathvariant="bold">AA</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq61.gif"/></alternatives></inline-formula>, <inline-formula id="IEq62"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left\| {\mathbf{A}} \right\|_{2,1} = Tr\left( {{\mathbf{A}}^{T} {\mathbf{D}}_{1} {\mathbf{A}}} \right)$$\end{document}</tex-math><mml:math id="M152"><mml:mrow><mml:msub><mml:mfenced close="∥" open="∥"><mml:mi mathvariant="bold">A</mml:mi></mml:mfenced><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">A</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi mathvariant="bold">A</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq62.gif"/></alternatives></inline-formula> and <inline-formula id="IEq63"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left\| {\mathbf{B}} \right\|_{2,1} = Tr\left( {{\mathbf{B}}^{T} {\mathbf{D}}_{2} {\mathbf{B}}} \right)$$\end{document}</tex-math><mml:math id="M154"><mml:mrow><mml:msub><mml:mfenced close="∥" open="∥"><mml:mi mathvariant="bold">B</mml:mi></mml:mfenced><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>T</mml:mi><mml:mi>r</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">B</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msup><mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq63.gif"/></alternatives></inline-formula>.<inline-formula id="IEq64"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{D}}_{1}$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq64.gif"/></alternatives></inline-formula>, <inline-formula id="IEq65"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{D}}_{2}$$\end{document}</tex-math><mml:math id="M158"><mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq65.gif"/></alternatives></inline-formula> are two diagonal matrices, where the values of the <inline-formula id="IEq66"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j$$\end{document}</tex-math><mml:math id="M160"><mml:mi>j</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq66.gif"/></alternatives></inline-formula>-th diagonal element are denoted as <inline-formula id="IEq67"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{jj}^{1} = {1 \mathord{\left/ {\vphantom {1 {2||\left( {\mathbf{A}} \right)^{j} ||}}} \right. \kern-\nulldelimiterspace} {2||\left( {\mathbf{A}} \right)^{j} ||}}_{2}$$\end{document}</tex-math><mml:math id="M162"><mml:mrow><mml:msubsup><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">jj</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msup><mml:mfenced close=")" open="("><mml:mi mathvariant="bold">A</mml:mi></mml:mfenced><mml:mi>j</mml:mi></mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq67.gif"/></alternatives></inline-formula>, <inline-formula id="IEq68"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{jj}^{2} = {1 \mathord{\left/ {\vphantom {1 {2||\left( {\mathbf{B}} \right)^{j} ||}}} \right. \kern-\nulldelimiterspace} {2||\left( {\mathbf{B}} \right)^{j} ||}}_{2}$$\end{document}</tex-math><mml:math id="M164"><mml:mrow><mml:msubsup><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">jj</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mn>1</mml:mn><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msup><mml:mfenced close=")" open="("><mml:mi mathvariant="bold">B</mml:mi></mml:mfenced><mml:mi>j</mml:mi></mml:msup><mml:mrow><mml:mo stretchy="false">|</mml:mo><mml:mo stretchy="false">|</mml:mo></mml:mrow></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq68.gif"/></alternatives></inline-formula>, respectively.</p>
      <p id="Par42">The first term is to construct an approximate model, the purpose is to find the matrix <inline-formula id="IEq69"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M166"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq69.gif"/></alternatives></inline-formula> and <inline-formula id="IEq70"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M168"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq70.gif"/></alternatives></inline-formula>. The second part is to add the Tikhonov regularization terms to prevent overfitting. The third part is to add the L<sub>2,1</sub>-norm to matrix <inline-formula id="IEq71"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M170"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq71.gif"/></alternatives></inline-formula>. The fourth part is to add the L<sub>2,1</sub>-norm to matrix <inline-formula id="IEq72"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M172"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq72.gif"/></alternatives></inline-formula>.The last two parts are the collaborative regularization terms of lncRNA expression similarity matrix and disease semantic similarity matrix. A detailed flow chart of the DSCMF method is shown in Fig. <xref rid="Fig8" ref-type="fig">8</xref>.<fig id="Fig8"><label>Fig. 8</label><caption><p>Method flow chart. The DSCMF method consists of two parts. First, the matrix <inline-formula id="IEq90"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{Y}}$$\end{document}</tex-math><mml:math id="M174"><mml:mi mathvariant="bold">Y</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq90.gif"/></alternatives></inline-formula> is decomposed into <inline-formula id="IEq91"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M176"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq91.gif"/></alternatives></inline-formula> and <inline-formula id="IEq92"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M178"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq92.gif"/></alternatives></inline-formula>, and L<sub>2,1</sub>-norm is added to <inline-formula id="IEq93"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M180"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq93.gif"/></alternatives></inline-formula> and <inline-formula id="IEq94"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M182"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq94.gif"/></alternatives></inline-formula>, respectively. Second is to join the GIP kernel in the CMF method</p></caption><graphic xlink:href="12859_2020_3868_Fig8_HTML" id="MO8"/></fig></p>
    </sec>
    <sec id="Sec18">
      <title>Optimization and algorithm of DSCMF method</title>
      <p id="Par43">In this paper, we use the least squares method to update <inline-formula id="IEq73"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M184"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq73.gif"/></alternatives></inline-formula> and <inline-formula id="IEq74"><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M186"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq74.gif"/></alternatives></inline-formula> to optimize the new method of this paper. In the first step, the values of <inline-formula id="IEq75"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M188"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq75.gif"/></alternatives></inline-formula> and <inline-formula id="IEq76"><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M190"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq76.gif"/></alternatives></inline-formula> need to be initialized, so the singular value decomposition (SVD) method is used in this paper. The initial formula is:<disp-formula id="Equ13"><label>13</label><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left[ {{\mathbf{U}},{\mathbf{S}},{\mathbf{V}}} \right] = SVD({\mathbf{Y}},k),{\mathbf{A}} = {\mathbf{US}}_{k}^{{{\raise0.7ex\hbox{$1$} \!\mathord{\left/ {\vphantom {1 2}}\right.\kern-\nulldelimiterspace} \!\lower0.7ex\hbox{$2$}}}} ,{\mathbf{B}} = {\mathbf{VS}}_{k}^{{{\raise0.7ex\hbox{$1$} \!\mathord{\left/ {\vphantom {1 2}}\right.\kern-\nulldelimiterspace} \!\lower0.7ex\hbox{$2$}}}} ,$$\end{document}</tex-math><mml:math id="M192" display="block"><mml:mrow><mml:mfenced close="]" open="["><mml:mrow><mml:mi mathvariant="bold">U</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">S</mml:mi><mml:mo>,</mml:mo><mml:mi mathvariant="bold">V</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mi>S</mml:mi><mml:mi>V</mml:mi><mml:mi>D</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>,</mml:mo><mml:mi>k</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mi mathvariant="bold">A</mml:mi><mml:mo>=</mml:mo><mml:msubsup><mml:mi mathvariant="bold">US</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mfrac bevelled="true"><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:mi mathvariant="bold">B</mml:mi><mml:mo>=</mml:mo><mml:msubsup><mml:mi mathvariant="bold">VS</mml:mi><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mfrac bevelled="true"><mml:mn>1</mml:mn><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:msubsup><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ13.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq77"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{S}}_{k}$$\end{document}</tex-math><mml:math id="M194"><mml:msub><mml:mi mathvariant="bold">S</mml:mi><mml:mi>k</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq77.gif"/></alternatives></inline-formula> represents a diagonal matrix that contains the <inline-formula id="IEq78"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$k$$\end{document}</tex-math><mml:math id="M196"><mml:mi>k</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq78.gif"/></alternatives></inline-formula> largest singular values. Next, based on the objective function, the partial derivatives are obtained for <inline-formula id="IEq79"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M198"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq79.gif"/></alternatives></inline-formula> and <inline-formula id="IEq80"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M200"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq80.gif"/></alternatives></inline-formula>, respectively, and their partial derivatives are zero. Finally, updating is stopped once <inline-formula id="IEq81"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}}$$\end{document}</tex-math><mml:math id="M202"><mml:mi mathvariant="bold">A</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq81.gif"/></alternatives></inline-formula> and <inline-formula id="IEq82"><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}}$$\end{document}</tex-math><mml:math id="M204"><mml:mi mathvariant="bold">B</mml:mi></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq82.gif"/></alternatives></inline-formula> converge. The iteration formula is as follows:<disp-formula id="Equ14"><label>14</label><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{A}} = \left( {{\mathbf{YB}} + \lambda_{l} {\mathbf{K}}_{l} {\mathbf{A}}} \right)\left( {{\mathbf{B}}^{\text{T}} {\mathbf{B}} + \lambda_{h} {\mathbf{I}}_{\text{k}} + \lambda_{l} {\mathbf{A}}^{\text{T}} {\mathbf{A}} + \lambda_{h} {\mathbf{D}}_{1} {\mathbf{I}}_{K} } \right)^{ - 1} ,$$\end{document}</tex-math><mml:math id="M206" display="block"><mml:mrow><mml:mi mathvariant="bold">A</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi mathvariant="bold">YB</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mi mathvariant="bold">A</mml:mi></mml:mrow></mml:mfenced><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">B</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mtext>k</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant="bold">A</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mi>K</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ14.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ15"><label>15</label><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\mathbf{B}} = \left( {{\mathbf{Y}}^{\text{T}} {\mathbf{A}} + \lambda_{d} {\mathbf{K}}_{\text{d}} {\mathbf{B}}} \right)\left( {{\mathbf{A}}^{\text{T}} {\mathbf{A}} + \lambda_{h} {\mathbf{I}}_{\text{k}} + \lambda_{d} {\mathbf{B}}^{\text{T}} {\mathbf{B}} + \lambda_{h} {\mathbf{D}}_{2} {\mathbf{I}}_{\text{k}} } \right)^{ - 1} ,$$\end{document}</tex-math><mml:math id="M208" display="block"><mml:mrow><mml:mi mathvariant="bold">B</mml:mi><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">Y</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">K</mml:mi><mml:mtext>d</mml:mtext></mml:msub><mml:mi mathvariant="bold">B</mml:mi></mml:mrow></mml:mfenced><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msup><mml:mrow><mml:mi mathvariant="bold">A</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:mi mathvariant="bold">A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mtext>k</mml:mtext></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mi mathvariant="bold">B</mml:mi></mml:mrow><mml:mtext>T</mml:mtext></mml:msup><mml:mi mathvariant="bold">B</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:msub><mml:mi mathvariant="bold">D</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="bold">I</mml:mi><mml:mtext>k</mml:mtext></mml:msub></mml:mrow></mml:mfenced><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="12859_2020_3868_Article_Equ15.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq83"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{h}$$\end{document}</tex-math><mml:math id="M210"><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq83.gif"/></alternatives></inline-formula>, <inline-formula id="IEq84"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{l}$$\end{document}</tex-math><mml:math id="M212"><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq84.gif"/></alternatives></inline-formula> and <inline-formula id="IEq85"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{d}$$\end{document}</tex-math><mml:math id="M214"><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq85.gif"/></alternatives></inline-formula> are a combination of the best parameters automatically selected from <inline-formula id="IEq86"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\lambda_{h} \in \left\{ {2^{ - 2} ,2^{ - 1} ,2^{0} ,2^{1} } \right\}$$\end{document}</tex-math><mml:math id="M216"><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>h</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>2</mml:mn><mml:mn>0</mml:mn></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>2</mml:mn><mml:mn>1</mml:mn></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq86.gif"/></alternatives></inline-formula> and <inline-formula id="IEq87"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${{\lambda_{l} } \mathord{\left/ {\vphantom {{\lambda_{l} } {\lambda_{d} }}} \right. \kern-\nulldelimiterspace} {\lambda_{d} }} \in \left\{ {0,10^{ - 4} ,10^{ - 3} ,10^{ - 2} ,10^{ - 1} } \right\}$$\end{document}</tex-math><mml:math id="M218"><mml:mrow><mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="true">/</mml:mo></mml:mrow><mml:msub><mml:mi>λ</mml:mi><mml:mi>d</mml:mi></mml:msub></mml:mrow><mml:mo>∈</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>4</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:msup><mml:mn>10</mml:mn><mml:mrow><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msup></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2020_3868_Article_IEq87.gif"/></alternatives></inline-formula>.</p>
      <p id="Par44">Through the detailed description of the above process, the algorithm of the DSCMF method can be organized as follows:<graphic position="anchor" xlink:href="12859_2020_3868_Figa_HTML" id="MO151"/></p>
      <p id="Par45">The DSCMF method is convergent. The maximum number of iterations is set to 100 times during the experiment, in order to find the local optimal solution of the objective function. The convergence curve is shown in Fig. <xref rid="Fig9" ref-type="fig">9</xref>. The algorithm tends to converge in about 10 times, which proves that our algorithm can converge quickly.<fig id="Fig9"><label>Fig. 9</label><caption><p>Convergence curve of the DSCMF method. When the number of iterations is about ten, our method tends to converge</p></caption><graphic xlink:href="12859_2020_3868_Fig9_HTML" id="MO9"/></fig></p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>DSCMF</term>
        <def>
          <p id="Par4">Dual sparse collaborative matrix factorization</p>
        </def>
      </def-item>
      <def-item>
        <term>GIP</term>
        <def>
          <p id="Par5">Gaussian interaction profile</p>
        </def>
      </def-item>
      <def-item>
        <term>WKNKN</term>
        <def>
          <p id="Par6">Weighted K nearest known neighbors</p>
        </def>
      </def-item>
      <def-item>
        <term>CV</term>
        <def>
          <p id="Par7">Cross-validation</p>
        </def>
      </def-item>
      <def-item>
        <term>SVD</term>
        <def>
          <p id="Par8">Singular value decomposition</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Thanks go to the editor and the anonymous reviewers for their comments and suggestions.</p>
    <sec id="d32e5181">
      <title>About this supplement</title>
      <p>This article has been published as part of <italic>BMC Bioinformatics Volume 22 Supplement 3, 2021: Proceedings of the 2019 International Conference on Intelligent Computing (ICIC 2019): bioinformatics</italic>. The full contents of the supplement are available online at <ext-link ext-link-type="uri" xlink:href="https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-22-supplement-3">https://bmcbioinformatics.biomedcentral.com/articles/supplements/volume-22-supplement-3</ext-link>.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>JXL and MMG jointly contributed to the design of the study. ZC designed and implemented the DSCMF method, performed the experiments, and drafted the manuscript. YLG participated in the design of the study and performed the statistical analysis. FL contributed to the data analysis. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>Publication costs are funded by the National Natural Science Foundation of China under Grant Nos. 61872220 and 61902216. The funder played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>The datasets that support the findings of this study are available in <ext-link ext-link-type="uri" xlink:href="https://www.cuilab.cn/lncrnadisease">https://www.cuilab.cn/lncrnadisease</ext-link>.</p>
  </notes>
  <notes id="FPar1">
    <title>Ethics approval and consent to participate</title>
    <p id="Par47">Not applicable.</p>
  </notes>
  <notes id="FPar2">
    <title>Consent for publication</title>
    <p id="Par48">Not applicable.</p>
  </notes>
  <notes id="FPar3" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par49">The authors declare that they have no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ponting</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Oliver</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Reik</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Evolution and functions of long noncoding RNAs</article-title>
        <source>Cell</source>
        <year>2009</year>
        <volume>136</volume>
        <fpage>629</fpage>
        <lpage>641</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2009.02.006</pub-id>
        <?supplied-pmid 19239885?>
        <pub-id pub-id-type="pmid">19239885</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>LncRNA structural characteristics in epigenetic regulation</article-title>
        <source>Int J Mol Sci</source>
        <year>2017</year>
        <volume>18</volume>
        <fpage>2659</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms18122659</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wapinski</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>HY</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNAs and human disease</article-title>
        <source>Trends Cell Biol</source>
        <year>2011</year>
        <volume>21</volume>
        <fpage>354</fpage>
        <lpage>361</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tcb.2011.04.001</pub-id>
        <?supplied-pmid 21550244?>
        <pub-id pub-id-type="pmid">21550244</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <mixed-citation publication-type="other">Alvarez-Dominguez JR, Hu W, Lodish HF. Regulation of eukaryotic cell differentiation by long non-coding RNAs. In: Molecular biology of long non-coding RNAs. Springer; 2013. p. 15–67.</mixed-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Micheletti</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Plaisance</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Abraham</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Sarre</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ting</surname>
            <given-names>C-C</given-names>
          </name>
          <name>
            <surname>Alexanian</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Maric</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Maison</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Nemir</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>RA</given-names>
          </name>
        </person-group>
        <article-title>The long noncoding RNA Wisper controls cardiac fibrosis and remodeling</article-title>
        <source>Sci Transl Med</source>
        <year>2017</year>
        <volume>9</volume>
        <fpage>eaai9118</fpage>
        <pub-id pub-id-type="doi">10.1126/scitranslmed.aai9118</pub-id>
        <?supplied-pmid 28637928?>
        <pub-id pub-id-type="pmid">28637928</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>YP</given-names>
          </name>
          <name>
            <surname>Hedrick</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Gaddis</surname>
            <given-names>DE</given-names>
          </name>
        </person-group>
        <article-title>Hematopoietic stem cells gone rogue</article-title>
        <source>Science</source>
        <year>2017</year>
        <volume>355</volume>
        <fpage>798</fpage>
        <lpage>799</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aam7939</pub-id>
        <?supplied-pmid 28232539?>
        <pub-id pub-id-type="pmid">28232539</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bai</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Geng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNA LINC01619 regulates microRNA-27a/forkhead box protein O1 and endoplasmic reticulum stress-mediated podocyte injury in diabetic nephropathy</article-title>
        <source>Antioxid Redox Signal</source>
        <year>2018</year>
        <volume>29</volume>
        <fpage>355</fpage>
        <lpage>376</lpage>
        <pub-id pub-id-type="doi">10.1089/ars.2017.7278</pub-id>
        <?supplied-pmid 29334763?>
        <pub-id pub-id-type="pmid">29334763</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNAs and Alzheimer’s disease</article-title>
        <source>Clin Interv Aging</source>
        <year>2016</year>
        <volume>11</volume>
        <fpage>867</fpage>
        <pub-id pub-id-type="doi">10.2147/CIA.S107037</pub-id>
        <?supplied-pmid 27418812?>
        <pub-id pub-id-type="pmid">27418812</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Änkö</surname>
            <given-names>M-L</given-names>
          </name>
          <name>
            <surname>Neugebauer</surname>
            <given-names>KM</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNAs add another layer to pre-mRNA splicing regulation</article-title>
        <source>Mol Cell</source>
        <year>2010</year>
        <volume>39</volume>
        <fpage>833</fpage>
        <lpage>834</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.003</pub-id>
        <?supplied-pmid 20864030?>
        <pub-id pub-id-type="pmid">20864030</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Expression of MALAT1 in the peripheral whole blood of patients with lung cancer</article-title>
        <source>Biomed Rep</source>
        <year>2015</year>
        <volume>3</volume>
        <fpage>309</fpage>
        <lpage>312</lpage>
        <pub-id pub-id-type="doi">10.3892/br.2015.422</pub-id>
        <?supplied-pmid 26137228?>
        <pub-id pub-id-type="pmid">26137228</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xiao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma</article-title>
        <source>Oncotarget</source>
        <year>2015</year>
        <volume>6</volume>
        <fpage>38005</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.5357</pub-id>
        <?supplied-pmid 26461224?>
        <pub-id pub-id-type="pmid">26461224</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients</article-title>
        <source>Biomed Pharmacother</source>
        <year>2016</year>
        <volume>83</volume>
        <fpage>8</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.biopha.2016.05.044</pub-id>
        <?supplied-pmid 27470544?>
        <pub-id pub-id-type="pmid">27470544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fayda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Isin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tambas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Guveli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Meral</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Altun</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sahin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ozkan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sanli</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Isin</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Do circulating long non-coding RNAs (lncRNAs)(LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?</article-title>
        <source>Tumor Biol</source>
        <year>2016</year>
        <volume>37</volume>
        <fpage>3969</fpage>
        <lpage>3978</lpage>
        <pub-id pub-id-type="doi">10.1007/s13277-015-4189-1</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lucafò</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Di Silvestre</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Romano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Avian</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Antonelli</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Martelossi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Naviglio</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tommasini</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stocco</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Ventura</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Role of the long non-coding rna growth arrest-specific 5 in glucocorticoid response in children with inflammatory bowel disease</article-title>
        <source>Basic Clin Pharmacol Toxicol</source>
        <year>2018</year>
        <volume>122</volume>
        <fpage>87</fpage>
        <lpage>93</lpage>
        <pub-id pub-id-type="doi">10.1111/bcpt.12851</pub-id>
        <?supplied-pmid 28722800?>
        <pub-id pub-id-type="pmid">28722800</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guo</surname>
            <given-names>L-J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X-H</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>W-G</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>J-J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>C-Y</given-names>
          </name>
        </person-group>
        <article-title>Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer</article-title>
        <source>Exp Mol Pathol</source>
        <year>2017</year>
        <volume>102</volume>
        <fpage>500</fpage>
        <lpage>504</lpage>
        <pub-id pub-id-type="doi">10.1016/j.yexmp.2017.05.008</pub-id>
        <?supplied-pmid 28506768?>
        <pub-id pub-id-type="pmid">28506768</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>S-S</given-names>
          </name>
        </person-group>
        <article-title>LncRNA-disease associations prediction using bipartite local model with nearest profile-based association inferring</article-title>
        <source>IEEE J Biomed Health Inform</source>
        <year>2019</year>
        <volume>24</volume>
        <fpage>1519</fpage>
        <lpage>1527</lpage>
        <pub-id pub-id-type="doi">10.1109/JBHI.2019.2937827</pub-id>
        <?supplied-pmid 31478878?>
        <pub-id pub-id-type="pmid">31478878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network</article-title>
        <source>Mol BioSyst</source>
        <year>2014</year>
        <volume>10</volume>
        <fpage>2074</fpage>
        <lpage>2081</lpage>
        <pub-id pub-id-type="doi">10.1039/C3MB70608G</pub-id>
        <?supplied-pmid 24850297?>
        <pub-id pub-id-type="pmid">24850297</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>IRWRLDA: improved random walk with restart for lncRNA-disease association prediction</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>57919</fpage>
        <lpage>57931</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.11141</pub-id>
        <?supplied-pmid 27517318?>
        <pub-id pub-id-type="pmid">27517318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G-Y</given-names>
          </name>
        </person-group>
        <article-title>Novel human lncRNA-disease association inference based on lncRNA expression profiles</article-title>
        <source>Bioinformatics</source>
        <year>2013</year>
        <volume>29</volume>
        <fpage>2617</fpage>
        <lpage>2624</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt426</pub-id>
        <?supplied-pmid 24002109?>
        <pub-id pub-id-type="pmid">24002109</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>KATZLDA: KATZ measure for the lncRNA-disease association prediction</article-title>
        <source>Sci Rep</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>16840</fpage>
        <pub-id pub-id-type="doi">10.1038/srep16840</pub-id>
        <?supplied-pmid 26577439?>
        <pub-id pub-id-type="pmid">26577439</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ding</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph</article-title>
        <source>Sci Rep</source>
        <year>2018</year>
        <volume>8</volume>
        <fpage>1065</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-19357-3</pub-id>
        <?supplied-pmid 29348552?>
        <pub-id pub-id-type="pmid">29348552</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ping</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Kuang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Iqbal</surname>
            <given-names>MFB</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>A novel method for lncRNA-disease association prediction based on an lncRNA-disease association network</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2018</year>
        <volume>16</volume>
        <fpage>688</fpage>
        <lpage>693</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2018.2827373</pub-id>
        <?supplied-pmid 29993639?>
        <pub-id pub-id-type="pmid">29993639</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kuang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xuan</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>A novel approach for predicting disease-lncRNA associations based on the distance correlation set and information of the miRNAs</article-title>
        <source>Comput Math Methods Med.</source>
        <year>2018</year>
        <volume>2018</volume>
        <fpage>6747453</fpage>
        <?supplied-pmid 30046354?>
        <pub-id pub-id-type="pmid">30046354</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ou-Yang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X-F</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y-R</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>LncRNA-disease association prediction using two-side sparse self-representation</article-title>
        <source>Front Genet</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>476</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2019.00476</pub-id>
        <?supplied-pmid 31191605?>
        <pub-id pub-id-type="pmid">31191605</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Domeniconi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Matrix factorization-based data fusion for the prediction of lncRNA–disease associations</article-title>
        <source>Bioinformatics</source>
        <year>2017</year>
        <volume>34</volume>
        <fpage>1529</fpage>
        <lpage>1537</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx794</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>L-Y</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>S-S</given-names>
          </name>
        </person-group>
        <article-title>L 2, 1-GRMF: an improved graph regularized matrix factorization method to predict drug-target interactions</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>287</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-2768-7</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>L-Y</given-names>
          </name>
        </person-group>
        <article-title>The computational prediction of drug-disease interactions using the dual-network L 2, 1-CMF method</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <fpage>5</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-018-2575-6</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>M-M</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J-X</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>C-H</given-names>
          </name>
        </person-group>
        <article-title>Dual-network sparse graph regularized matrix factorization for predicting miRNA-disease associations</article-title>
        <source>Mol Omics</source>
        <year>2019</year>
        <volume>15</volume>
        <fpage>130</fpage>
        <lpage>137</lpage>
        <pub-id pub-id-type="doi">10.1039/C8MO00244D</pub-id>
        <?supplied-pmid 30723850?>
        <pub-id pub-id-type="pmid">30723850</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>LncRNADisease: a database for long-non-coding RNA-associated diseases</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>41</volume>
        <fpage>D983</fpage>
        <lpage>D986</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1099</pub-id>
        <?supplied-pmid 23175614?>
        <pub-id pub-id-type="pmid">23175614</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Parkinson</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kapushesky</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shojatalab</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Abeygunawardena</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Coulson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Farne</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Holloway</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kolesnykov</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lilja</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lukk</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>ArrayExpress—a public database of microarray experiments and gene expression profiles</article-title>
        <source>Nucleic Acids Res</source>
        <year>2006</year>
        <volume>35</volume>
        <fpage>D747</fpage>
        <lpage>D750</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkl995</pub-id>
        <?supplied-pmid 17132828?>
        <pub-id pub-id-type="pmid">17132828</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alaimo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Giugno</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Pulvirenti</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>ncPred: ncRNA-disease association prediction through tripartite network-based inference</article-title>
        <source>Front Bioeng Biotechnol</source>
        <year>2014</year>
        <volume>2</volume>
        <fpage>71</fpage>
        <pub-id pub-id-type="doi">10.3389/fbioe.2014.00071</pub-id>
        <?supplied-pmid 25566534?>
        <pub-id pub-id-type="pmid">25566534</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>NTSHMDA: prediction of human microbe-disease association based on random walk by integrating network topological similarity</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform.</source>
        <year>2020</year>
        <volume>17</volume>
        <issue>4</issue>
        <fpage>1341</fpage>
        <lpage>1351</lpage>
        <?supplied-pmid 30489271?>
        <pub-id pub-id-type="pmid">30489271</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ling</surname>
            <given-names>CX</given-names>
          </name>
        </person-group>
        <article-title>Using AUC and accuracy in evaluating learning algorithms</article-title>
        <source>IEEE Trans Knowl Data Eng</source>
        <year>2005</year>
        <volume>17</volume>
        <fpage>299</fpage>
        <lpage>310</lpage>
        <pub-id pub-id-type="doi">10.1109/TKDE.2005.50</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Du</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hacisuleyman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Fei</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rinn</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>MG-S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kantoff</surname>
            <given-names>PW</given-names>
          </name>
        </person-group>
        <article-title>Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer</article-title>
        <source>Nat Commun</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>10982</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms10982</pub-id>
        <?supplied-pmid 26975529?>
        <pub-id pub-id-type="pmid">26975529</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Eeles</surname>
            <given-names>RA</given-names>
          </name>
          <name>
            <surname>Kote-Jarai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Al Olama</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Giles</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Guy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Severi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Muir</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hopper</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Henderson</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Haiman</surname>
            <given-names>CA</given-names>
          </name>
        </person-group>
        <article-title>Identification of seven new prostate cancer susceptibility loci through a genome-wide association study</article-title>
        <source>Nat Genet</source>
        <year>2009</year>
        <volume>41</volume>
        <fpage>1116</fpage>
        <pub-id pub-id-type="doi">10.1038/ng.450</pub-id>
        <?supplied-pmid 19767753?>
        <pub-id pub-id-type="pmid">19767753</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheetham</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Gruhl</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mattick</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dinger</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNAs and the genetics of cancer</article-title>
        <source>Br J Cancer</source>
        <year>2013</year>
        <volume>108</volume>
        <fpage>2419</fpage>
        <pub-id pub-id-type="doi">10.1038/bjc.2013.233</pub-id>
        <?supplied-pmid 3694235?>
        <pub-id pub-id-type="pmid">23660942</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Du</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Weng</surname>
            <given-names>X-D</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X-H</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>H-C</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ning</surname>
            <given-names>J-Z</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>C-C</given-names>
          </name>
        </person-group>
        <article-title>LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression</article-title>
        <source>Oncotarget</source>
        <year>2017</year>
        <volume>8</volume>
        <fpage>94358</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.21719</pub-id>
        <?supplied-pmid 29212233?>
        <pub-id pub-id-type="pmid">29212233</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Martens-Uzunova</surname>
            <given-names>ES</given-names>
          </name>
          <name>
            <surname>Böttcher</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Croce</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Jenster</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Visakorpi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Calin</surname>
            <given-names>GA</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNA in prostate, bladder, and kidney cancer</article-title>
        <source>Eur Urol</source>
        <year>2014</year>
        <volume>65</volume>
        <fpage>1140</fpage>
        <lpage>1151</lpage>
        <pub-id pub-id-type="doi">10.1016/j.eururo.2013.12.003</pub-id>
        <?supplied-pmid 24373479?>
        <pub-id pub-id-type="pmid">24373479</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Poliseno</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Salmena</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carver</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Haveman</surname>
            <given-names>WJ</given-names>
          </name>
          <name>
            <surname>Pandolfi</surname>
            <given-names>PP</given-names>
          </name>
        </person-group>
        <article-title>A coding-independent function of gene and pseudogene mRNAs regulates tumour biology</article-title>
        <source>Nature</source>
        <year>2010</year>
        <volume>465</volume>
        <fpage>1033</fpage>
        <pub-id pub-id-type="doi">10.1038/nature09144</pub-id>
        <?supplied-pmid 3206313?>
        <pub-id pub-id-type="pmid">20577206</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>X-F</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer</article-title>
        <source>Int J Clin Exp Pathol</source>
        <year>2015</year>
        <volume>8</volume>
        <fpage>9440</fpage>
        <?supplied-pmid 26464701?>
        <pub-id pub-id-type="pmid">26464701</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <mixed-citation publication-type="other">Zhao X-B, Ren G-S. WITHDRAWN: LncRNA TUG1 promotes breast cancer cell proliferation via inhibiting miR-9. Cancer Biomark Sect A Dis Markers. 2016.</mixed-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J-H</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>Q-J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Z-K</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J-G</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>M-S</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>M-S</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways</article-title>
        <source>Oncol Lett</source>
        <year>2017</year>
        <volume>14</volume>
        <fpage>4659</fpage>
        <lpage>4662</lpage>
        <pub-id pub-id-type="doi">10.3892/ol.2017.6823</pub-id>
        <?supplied-pmid 29085464?>
        <pub-id pub-id-type="pmid">29085464</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cai</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Huo</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5</article-title>
        <source>Biochem Biophys Res Commun</source>
        <year>2017</year>
        <volume>485</volume>
        <fpage>272</fpage>
        <lpage>278</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbrc.2017.02.094</pub-id>
        <?supplied-pmid 28232182?>
        <pub-id pub-id-type="pmid">28232182</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Mo</surname>
            <given-names>Y-Y</given-names>
          </name>
        </person-group>
        <article-title>LncRNA loc285194 is a p53-regulated tumor suppressor</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <fpage>4976</fpage>
        <lpage>4987</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt182</pub-id>
        <?supplied-pmid 23558749?>
        <pub-id pub-id-type="pmid">23558749</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer</article-title>
        <source>Oncol Rep</source>
        <year>2016</year>
        <volume>36</volume>
        <fpage>3241</fpage>
        <lpage>3250</lpage>
        <pub-id pub-id-type="doi">10.3892/or.2016.5200</pub-id>
        <?supplied-pmid 27779700?>
        <pub-id pub-id-type="pmid">27779700</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer</article-title>
        <source>Eur Rev Med Pharmacol Sci</source>
        <year>2016</year>
        <volume>20</volume>
        <fpage>3373</fpage>
        <lpage>3377</lpage>
        <?supplied-pmid 27608895?>
        <pub-id pub-id-type="pmid">27608895</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition</article-title>
        <source>Biochem Biophys Res Commun</source>
        <year>2016</year>
        <volume>480</volume>
        <fpage>508</fpage>
        <lpage>514</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.08.120</pub-id>
        <?supplied-pmid 27558961?>
        <pub-id pub-id-type="pmid">27558961</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer</article-title>
        <source>Cancer Chemother Pharmacol</source>
        <year>2017</year>
        <volume>79</volume>
        <fpage>479</fpage>
        <lpage>487</lpage>
        <pub-id pub-id-type="doi">10.1007/s00280-017-3238-4</pub-id>
        <?supplied-pmid 28175963?>
        <pub-id pub-id-type="pmid">28175963</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNA SNHG16 promotes cell growth and metastasis in ovarian cancer</article-title>
        <source>Eur Rev Med Pharmacol Sci</source>
        <year>2018</year>
        <volume>22</volume>
        <fpage>616</fpage>
        <lpage>622</lpage>
        <?supplied-pmid 29461589?>
        <pub-id pub-id-type="pmid">29461589</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer</article-title>
        <source>Eur Rev Med Pharmacol Sci</source>
        <year>2017</year>
        <volume>21</volume>
        <fpage>5618</fpage>
        <lpage>5623</lpage>
        <?supplied-pmid 29271994?>
        <pub-id pub-id-type="pmid">29271994</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>C-F</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z-Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X-P</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>H-H</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNA expression signature to predict platinum-based chemotherapeutic sensitivity of ovarian cancer patients</article-title>
        <source>Sci Rep</source>
        <year>2017</year>
        <volume>7</volume>
        <fpage>18</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-017-00050-w</pub-id>
        <?supplied-pmid 28154416?>
        <pub-id pub-id-type="pmid">28154416</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial–mesenchymal transition</article-title>
        <source>OncoTargets Ther</source>
        <year>2016</year>
        <volume>9</volume>
        <fpage>5417</fpage>
        <lpage>5425</lpage>
        <pub-id pub-id-type="doi">10.2147/OTT.S111794</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ou</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>47536</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.9868</pub-id>
        <?supplied-pmid 27286457?>
        <pub-id pub-id-type="pmid">27286457</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNA TUG1 promotes colorectal cancer metastasis via EMT pathway</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <fpage>51713</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.10563</pub-id>
        <?supplied-pmid 27421138?>
        <pub-id pub-id-type="pmid">27421138</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Xing</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer</article-title>
        <source>Pathol Res Pract</source>
        <year>2016</year>
        <volume>212</volume>
        <fpage>690</fpage>
        <lpage>695</lpage>
        <pub-id pub-id-type="doi">10.1016/j.prp.2016.05.003</pub-id>
        <?supplied-pmid 27461828?>
        <pub-id pub-id-type="pmid">27461828</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Ji</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>Constructing lncRNA functional similarity network based on lncRNA-disease associations and disease semantic similarity</article-title>
        <source>Sci Rep</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>11338</fpage>
        <pub-id pub-id-type="doi">10.1038/srep11338</pub-id>
        <?supplied-pmid 26061969?>
        <pub-id pub-id-type="pmid">26061969</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>van Laarhoven</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nabuurs</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Marchiori</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Gaussian interaction profile kernels for predicting drug–target interaction</article-title>
        <source>Bioinformatics</source>
        <year>2011</year>
        <volume>27</volume>
        <fpage>3036</fpage>
        <lpage>3043</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btr500</pub-id>
        <?supplied-pmid 21893517?>
        <pub-id pub-id-type="pmid">21893517</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y-H</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nandi</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Honig</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>D-S</given-names>
          </name>
        </person-group>
        <article-title>miRNA-disease association prediction with collaborative matrix factorization</article-title>
        <source>Complexity.</source>
        <year>2017</year>
        <volume>2017</volume>
        <fpage>2498957</fpage>
        <pub-id pub-id-type="doi">10.1155/2017/2498957</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
